1.Environmental exposure to perchlorate, nitrate, and thiocyanate in relation to chronic kidney disease in the general US population, NHANES 2005-2016.
Wei LI ; Hong WU ; Xuewen XU ; Yange ZHANG
Chinese Medical Journal 2023;136(13):1573-1582
BACKGROUND:
Few studies have explored the impact of perchlorate, nitrate, and thiocyanate (PNT) on kidney function. This study aimed to evaluate the association of urinary levels of PNT with renal function as well as the prevalence of chronic kidney disease (CKD) among the general population in the United States.
METHODS:
This analysis included data from 13,373 adults (≥20 years) from the National Health and Nutrition Examination Survey 2005 to 2016. We used multivariable linear and logistic regression, to explore the associations of urinary PNT with kidney function. Restricted cubic splines were used to assess the potentially non-linear relationships between PNT exposure and outcomes.
RESULTS:
After traditional creatinine adjustment, perchlorate (P-traditional) was positively associated with estimated glomerular filtration rate (eGFR) (adjusted β: 2.75; 95% confidence interval [CI]: 2.25 to 3.26; P < 0.001), and negatively associated with urinary albumin-to-creatinine ratio (ACR) (adjusted β: -0.05; 95% CI: -0.07 to -0.02; P = 0.001) in adjusted models. After both traditional and covariate-adjusted creatinine adjustment, urinary nitrate and thiocyanate were positively associated with eGFR (all P values <0.05), and negatively associated with ACR (all P values <0.05); higher nitrate or thiocyanate was associated with a lower risk of CKD (all P values <0.001). Moreover, there were L-shaped non-linear associations between nitrate, thiocyanate, and outcomes. In the adjusted models, for quartiles of PNT, statistically significant dose-response associations were observed in most relationships. Most results were consistent in the stratified and sensitivity analyses.
CONCLUSIONS
Exposures to PNT might be associated with kidney function, indicating a potential beneficial effect of environmental PNT exposure (especially nitrate and thiocyanate) on the human kidney.
Adult
;
Humans
;
United States/epidemiology*
;
Nitrates/adverse effects*
;
Nutrition Surveys
;
Thiocyanates/urine*
;
Perchlorates/urine*
;
Creatinine
;
Environmental Exposure
;
Renal Insufficiency, Chronic/epidemiology*
;
Logistic Models
2.Decreased nitric oxide synthesis in rats with chronic renal failure.
Soo Wan KIM ; Jong Un LEE ; Yun Woong PAEK ; Dae Gill KANG ; Ki Chul CHOI
Journal of Korean Medical Science 2000;15(4):425-430
The present study was aimed at investigating whether an altered role of nitric oxide (NO) is involved in chronic renal failure (CRF). Rats were subjected to 5/6 nephrectomy and kept for 6 weeks to induce CRF. On the experimental day, after measurement of arterial pressure under anesthesia, the arterial blood was collected, and thoracic aorta and kidney were rapidly taken. NO metabolites (NOx) were determined in the plasma, urine, aorta and kidney. The expression of NO synthase (NOS) isozymes was determined in the kidney and aorta by Western blot analysis. The expression of NOS mRNA in the glomeruli was also determined by RT-PCR. There were significant increases in arterial pressure and serum creatinine levels in CRF. Urine NOx levels were decreased in CRF, whereas plasma NOx levels were not altered. Aorta and kidney tissue NOx levels were also decreased in CRF. The expression of endothelial constitutive (ec) and inducible (i) isoforms of NOS proteins was decreased in the kidney and aorta in CRF. Accordingly, the expression of ecNOS and iNOS mRNA was decreased in the glomeruli in CRF. In conclusion, NO synthesis is decreased in the kidney and vasculature of CRF rats.
Animal
;
Aorta, Thoracic/metabolism
;
Comparative Study
;
Enzyme Induction
;
Isoenzymes/metabolism+ACo-
;
Isoenzymes/genetics
;
Kidney/metabolism
;
Kidney Failure, Chronic/metabolism+ACo-
;
Male
;
Nephrectomy
;
Nitrates/urine
;
Nitrates/blood
;
Nitric Oxide/deficiency+ACo-
;
Nitric Oxide/biosynthesis
;
Nitric-Oxide Synthase/metabolism+ACo-
;
Nitric-Oxide Synthase/genetics
;
Nitrites/urine
;
Nitrites/blood
;
Organ Specificity
;
RNA, Messenger/biosynthesis
;
Rats
;
Rats, Sprague-Dawley
3.Decreased nitric oxide synthesis in rats with chronic renal failure.
Soo Wan KIM ; Jong Un LEE ; Yun Woong PAEK ; Dae Gill KANG ; Ki Chul CHOI
Journal of Korean Medical Science 2000;15(4):425-430
The present study was aimed at investigating whether an altered role of nitric oxide (NO) is involved in chronic renal failure (CRF). Rats were subjected to 5/6 nephrectomy and kept for 6 weeks to induce CRF. On the experimental day, after measurement of arterial pressure under anesthesia, the arterial blood was collected, and thoracic aorta and kidney were rapidly taken. NO metabolites (NOx) were determined in the plasma, urine, aorta and kidney. The expression of NO synthase (NOS) isozymes was determined in the kidney and aorta by Western blot analysis. The expression of NOS mRNA in the glomeruli was also determined by RT-PCR. There were significant increases in arterial pressure and serum creatinine levels in CRF. Urine NOx levels were decreased in CRF, whereas plasma NOx levels were not altered. Aorta and kidney tissue NOx levels were also decreased in CRF. The expression of endothelial constitutive (ec) and inducible (i) isoforms of NOS proteins was decreased in the kidney and aorta in CRF. Accordingly, the expression of ecNOS and iNOS mRNA was decreased in the glomeruli in CRF. In conclusion, NO synthesis is decreased in the kidney and vasculature of CRF rats.
Animal
;
Aorta, Thoracic/metabolism
;
Comparative Study
;
Enzyme Induction
;
Isoenzymes/metabolism+ACo-
;
Isoenzymes/genetics
;
Kidney/metabolism
;
Kidney Failure, Chronic/metabolism+ACo-
;
Male
;
Nephrectomy
;
Nitrates/urine
;
Nitrates/blood
;
Nitric Oxide/deficiency+ACo-
;
Nitric Oxide/biosynthesis
;
Nitric-Oxide Synthase/metabolism+ACo-
;
Nitric-Oxide Synthase/genetics
;
Nitrites/urine
;
Nitrites/blood
;
Organ Specificity
;
RNA, Messenger/biosynthesis
;
Rats
;
Rats, Sprague-Dawley
4.Erythropoietin does not affect nitric oxide system in rats with chronic renal failure.
Soo Wan KIM ; Jong Un LEE ; Dae Gill KANG ; Kwon JUNG ; Nam Ho KIM ; Soon Pal SUH ; Ki Chul CHOI ; Young Joon KANG
Journal of Korean Medical Science 2000;15(2):183-188
We investigated to see whether an altered role of nitric oxide (NO) system is involved in erythropoietin (EPO)-induced hypertension in chronic renal failure (CRF). Male Sprague-Dawley rats were five-sixths nephrectomized to induce CRF. Six weeks after the operation, EPO or vehicle was injected for another 6 weeks. Plasma and urine nitrite/nitrate (NOx) levels were determined. Expression of NO synthase (NOS) proteins in the aortae and kidneys were also determined. In addition, the isometric tension of isolated aorta in response to acetylcholine and nitroprusside was examined. Blood pressure progressively rose in CRF groups, the degree of which was augmented by EPO treatment. Plasma NOx levels did not differ among the groups, while urine NOx levels were lower in CRF groups. Endothelial NOS expression was lower in the kidney and aorta in CRF rats, which was not further affected by EPO-treatment. The inducible NOS expression in the kidney and aorta was not different among the groups. Acetylcholine and sodium nitroprusside caused dose-dependent relaxations of aortic rings, the degree of which was not altered by EPO-treatment. Taken together, EPO-treatment aggravates hypertension in CRF, but altered role of NO system may not be involved.
Acetylcholine/pharmacology
;
Anemia/metabolism
;
Anemia/etiology
;
Anemia/drug therapy*
;
Animal
;
Aorta, Thoracic/physiology
;
Body Weight
;
Erythropoietin/pharmacology*
;
Hypertension, Renal/metabolism
;
Hypertension, Renal/drug therapy
;
Isometric Contraction/drug effects
;
Kidney/enzymology
;
Kidney Failure, Chronic/metabolism*
;
Kidney Failure, Chronic/complications
;
Male
;
Nitrates/urine
;
Nitrates/blood
;
Nitric Oxide/metabolism*
;
Nitric-Oxide Synthase/metabolism
;
Nitrites/urine
;
Nitrites/blood
;
Nitroprusside/pharmacology
;
Rats
;
Rats, Sprague-Dawley
;
Vasoconstriction/drug effects
;
Vasoconstrictor Agents/pharmacology
;
Vasodilator Agents/pharmacology